Effects of sodium lactate infusion in patients with glucose transporter 1 deficiency syndrome (GLUT1DS)

未提供0 个研究点目标入组 4 人开始时间: 2020年6月9日最近更新: 2021年7月26日

试验速览

暂无简介。

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•- Diagnosed with GLUT1DS and known in our center.
•- Baseline characteristics include a high frequency of clinical seizures and epileptic discharges on EEG.
•- History of trying ketogenic diet with good compliance but without beneficial effects.
•- Age > 6 years.
•- Informed consent.
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 4
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•A potential subject who meets any of the following criteria will be excluded from participation in this study:
•- Additional medical condition or illness that impairs the patient’s ability to participate in the study (for example actual treatment of a malignancy, active infection, poorly controlled diabetes mellitus, hypertension, organ failure, clinically significant haematological or biochemical abnormalities).
•- Elevated serum sodium (> 145 mmol/L).
•- Participation in another interventional study at start of the study or during the study.
•- Presence of known panic disorders or a history of panic attacks.

发起方

未提供